Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c

The introduction of highly efficient therapies with direct-acting antivirals (DAA) for patients with chronic hepatitis C virus (HCV) infection offers exceptional opportunities to globally control this deadly disease. For achieving this ambitious goal, it is essential to prevent antiviral resistance...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Ramirez, Santseharay, Fernandez-Antunez, Carlota, Mikkelsen, Lotte S., Pedersen, Jannie, Li, Yi-Ping, Bukh, Jens
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2020
Subjects:
Antiviral Agents
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7038289/
https://ncbi.nlm.nih.gov/pubmed/31818814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01888-19
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items